CoChat

Reduced Insulin Exocytosis in Human Pancreatic β-Cells With Gene Variants Linked to Type 2 Diabetes

Open access

The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.

Abstract

The majority of genetic risk variants for type 2 diabetes (T2D) affect insulin secretion, but the mechanisms through which they influence pancreatic islet function remain largely unknown. We functionally characterized human islets to determine secretory, biophysical, and ultrastructural features in relation to genetic risk profiles in diabetic and nondiabetic donors. Islets from donors with T2D exhibited impaired insulin secretion, which was more pronounced in lean than obese diabetic donors. We assessed the impact of 14 disease susceptibility variants on measures of glucose sensing, exocytosis, and structure. Variants near TCF7L2 and ADRA2A were associated with reduced glucose-induced insulin secretion, whereas susceptibility variants near ADRA2A, KCNJ11, KCNQ1, and TCF7L2 were associated with reduced depolarization-evoked insulin exocytosis. KCNQ1, ADRA2A, KCNJ11, HHEX/IDE, and SLC2A2 variants affected granule docking. We combined our results to create a novel genetic risk score for β-cell dysfunction that includes aberrant granule docking, decreased Ca2+ sensitivity of exocytosis, and reduced insulin release. Individuals with a high risk score displayed an impaired response to intravenous glucose and deteriorating insulin secretion over time. Our results underscore the importance of defects in β-cell exocytosis in T2D and demonstrate the potential of cellular phenotypic characterization in the elucidation of complex genetic disorders.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2337/db11-1516

Cites

42 of 42 references verified0 citation errors · 0 not checkable

Statistics

Figures

FIG. 1. Characterization of islets from diabetic and ND individuals. A: Fold-stimulation of insulin secretion by glucose in batch-incubated islets from non-T2D (n = 42) and T2D (n = 17) donors, nonobese (n = 37) and obese (n = 5) ND donors, as well as nonobese (n = 12) and obese T2D donors (n = 5). Fold-stimulation of insulin secretion in non-T2D and T2D donors separated by center (1, Lund; 2, Oxford) is also displayed. B: Total exocytosis evoked by a train of 10 depolarizations from −70 to 0 mV (ΣΔC) (n = 189 and 60 cells from 28 non-T2D and 8 T2D donors, respectively). C: Electron micrographs of human islets from non-T2D donors with low (25 kg/m2) and high (29 kg/m2) BMI. Lipid droplets (*), nucleus (N), and plasma membrane (PM, solid line) are indicated; dashed lines show 150-nm distance from PM. Scale bars, 0.5 μm. The histograms show the total granule number as volume density (Nv; granules/μm3) and the number of docked granules as surface density (Ns; granules/μm2) in β-cells from non-T2D and T2D donors (n = 75 and 42 cells from 12 and 6 donors, respectively). A granule was defined as docked when the center of the granule was located within 150 nm from the plasma membrane. Data are presented as means ± SEM. *P < 0.05 and **P < 0.01.
FIG. 1. Characterization of islets from diabetic and ND individuals. A: Fold-stimulation of insulin secretion by glucose in batch-incubated islets from non-T2D (n = 42) and T2D (n = 17) donors, nonobese (n = 37) and obese (n = 5) ND donors, as well as nonobese (n = 12) and obese T2D donors (n = 5). Fold-stimulation of insulin secretion in non-T2D and T2D donors separated by center (1, Lund; 2, Oxford) is also displayed. B: Total exocytosis evoked by a train of 10 depolarizations from −70 to 0 mV (ΣΔC) (n = 189 and 60 cells from 28 non-T2D and 8 T2D donors, respectively). C: Electron micrographs of human islets from non-T2D donors with low (25 kg/m2) and high (29 kg/m2) BMI. Lipid droplets (*), nucleus (N), and plasma membrane (PM, solid line) are indicated; dashed lines show 150-nm distance from PM. Scale bars, 0.5 μm. The histograms show the total granule number as volume density (Nv; granules/μm3) and the number of docked granules as surface density (Ns; granules/μm2) in β-cells from non-T2D and T2D donors (n = 75 and 42 cells from 12 and 6 donors, respectively). A granule was defined as docked when the center of the granule was located within 150 nm from the plasma membrane. Data are presented as means ± SEM. *P < 0.05 and **P < 0.01.CC BY-NC-ND · PubMed Central
FIG. 2. Genotype effects on insulin secretion and β-cell exocytosis. A: Glucose-stimulated insulin secretion in islets from different genotype carriers of rs7903146 (T is risk allele). Data from 28 CC, 17 CT, and 2 TT carriers. B: Glucose-stimulated insulin secretion in islets from donors with different genotype for rs553668 (A is risk allele). Data from 36 GG, 12 GA, and 2 AA carriers. C–F: Depolarization-evoked increase in cell capacitance (ΔC) in β-cells representative for individuals carrying risk or nonrisk alleles for rs7903146 (TCF7L2), rs553668 (ADRA2A), rs5219 (KCNJ11), and rs2237895 (KCNQ1). G and H: Exocytotic response in human β-cells treated with control siRNA or siRNA targeting KCNQ1. Histogram shows average total exocytosis (ΣΔC) from 22 and 21 cells per group, respectively. *P < 0.05.
FIG. 2. Genotype effects on insulin secretion and β-cell exocytosis. A: Glucose-stimulated insulin secretion in islets from different genotype carriers of rs7903146 (T is risk allele). Data from 28 CC, 17 CT, and 2 TT carriers. B: Glucose-stimulated insulin secretion in islets from donors with different genotype for rs553668 (A is risk allele). Data from 36 GG, 12 GA, and 2 AA carriers. C–F: Depolarization-evoked increase in cell capacitance (ΔC) in β-cells representative for individuals carrying risk or nonrisk alleles for rs7903146 (TCF7L2), rs553668 (ADRA2A), rs5219 (KCNJ11), and rs2237895 (KCNQ1). G and H: Exocytotic response in human β-cells treated with control siRNA or siRNA targeting KCNQ1. Histogram shows average total exocytosis (ΣΔC) from 22 and 21 cells per group, respectively. *P < 0.05.CC BY-NC-ND · PubMed Central
FIG. 3. Effects of the genetic risk score. A: Depolarization-evoked exocytosis in β-cells from donors with different scores. B: Electron micrographs of human islet sections from an individual with low (top) and high (bottom) score. Docked insulin granules (arrows), lipid droplets (*), nuclei (N), lipofusic bodies (LB), and plasma membrane (PM) are indicated. Left scale bars, 2 μm; right, 0.5 μm. C: Effects of the risk score on insulin secretion during IVGTT in 604 individuals. Data are means ± SEM. *P < 0.05.
FIG. 3. Effects of the genetic risk score. A: Depolarization-evoked exocytosis in β-cells from donors with different scores. B: Electron micrographs of human islet sections from an individual with low (top) and high (bottom) score. Docked insulin granules (arrows), lipid droplets (*), nuclei (N), lipofusic bodies (LB), and plasma membrane (PM) are indicated. Left scale bars, 2 μm; right, 0.5 μm. C: Effects of the risk score on insulin secretion during IVGTT in 604 individuals. Data are means ± SEM. *P < 0.05.CC BY-NC-ND · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Cited by

See all 237

Metadata

Authors
Rosengren, A. H., Braun, M., Mahdi, T., Andersson, S. A., Travers, M. E., Shigeto, M., Zhang, E., Almgren, P., Ladenvall, C., Axelsson, A. S., Edlund, A., Pedersen, M. G., Jonsson, A., Ramracheya, R., Tang, Y., Walker, J. N., Barrett, A., Johnson, P. R. V., Lyssenko, V., McCarthy, M. I., Groop, L., Salehi, A., Gloyn, A. L., Renström, E., Rorsman, P., & Eliasson, L.
Affiliations
  • Lund University (SE)
  • University of Alberta (CA)
  • Churchill Hospital (GB)
  • Centre for Human Genetics (GB)
Corresponding author
Eliasson, Lena
Venue
Diabetes
Published
2012-06-15
Volume
61
Issue
7
Pages
1726-1733
ISSN
  • 0012-1797 (ISSN-L)
  • 1939-327X
OpenAlex
W2168992353
Cited by
237
References
42
Citations by year
2026: 6 · 2025: 11 · 2024: 6 · 2023: 13 · 2022: 14 · 2021: 10 · 2020: 17 · 2019: 12 · 2018: 8 · 2017: 23 · 2016: 27 · 2015: 27 · 2014: 34 · 2013: 22 · 2012: 6
FWCI
28.99
Type
journal article
Language
en
Open access
Locations
  • Diabetes (publishedVersion, cc-by-nc-nd)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • Lund University Publications (Lund University) (submittedVersion)
  • Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
  • Padua Research Archive (University of Padova) (submittedVersion)
Funders
  • Wellcome Trust (095101, 095101/Z/10/Z, 095531/Z/11/Z, 090532, 095531)
  • Novo Nordisk Fonden (NNF10OC1013350)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
Keywords
type 2 diabetes, pancreatic beta cells, insulin exocytosis, insulin secretion, genetic risk variants, TCF7L2, ADRA2A, KCNJ11, KCNQ1, GLUT2, granule docking, glucose detection, calcium sensitivity, polygenic risk score, islet ultrastructure
MeSH terms
Insulin Secretion, Kcnj11 Channel, Cells, Cultured, Diabetes Mellitus, Type 2, Exocytosis, Humans, Insulin, Transcription Factors, Genetic Variation, Receptors, Adrenergic, alpha-2, Homeodomain Proteins, Genetic Predisposition to Disease, Potassium Channels, Inwardly Rectifying, Insulin-Secreting Cells, Glucose Transporter Type 2, KCNQ1 Potassium Channel, Transcription Factor 7-Like 2 Protein

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.